Wildtype uses cellular agriculture to grow fish muscle tissue in serum‑free bioreactors, creating fillets that match the taste, texture and nutrition of wild‑caught seafood. The closed‑loop production platform provides consistent, FDA‑compliant product at scale while reducing water use, land footprint and greenhouse‑gas emissions. It supplies seafood processors, restaurant chains and grocery retailers with a sustainable, reliable source of fish protein.
Funding
$7.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Global seafood demand is outpacing sustainable wild-catch capacity, leading to overfishing, ecosystem degradation, and volatile supply chains that limit consistent access to high-quality protein.
Solution
Wildtype applies cellular agriculture to produce fish muscle tissue directly from cultivated cells in controlled bioreactors, eliminating the need for traditional fishing. The process uses a defined, serum‑free growth medium and tissue‑engineering scaffolds to generate fillets that replicate the taste, texture, and nutritional profile of conventional seafood. By decoupling production from marine ecosystems, the company can scale output while reducing water use, land footprint, and greenhouse‑gas emissions. Real‑time bioprocess monitoring ensures batch‑to‑batch consistency and compliance with food‑safety standards. The resulting product can be integrated into existing seafood supply chains, offering retailers and foodservice operators a sustainable alternative without changing preparation methods.
Target Audience
Primary customers are seafood processors, restaurant chains, and grocery retailers seeking a reliable, environmentally responsible source of high‑quality fish protein for their product lines.
Features
- Serum‑free, chemically defined growth medium that supports rapid proliferation of fish myoblasts
- Scalable stainless‑steel bioreactor system with automated temperature, pH, and oxygen control
- 3‑D tissue‑engineering scaffold that aligns cells to form structured fillets mimicking whole‑cut fish
- Closed‑loop production line with continuous monitoring and AI‑driven process optimization
- Nutrient profiling and flavor‑enhancement protocols that match wild‑caught fish benchmarks
- Full compliance with FDA and international food‑safety regulations, including HACCP certification
- Modular platform that can be adapted to multiple species and product formats (e.g., fillets, nuggets)